{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T00:29:07Z","timestamp":1794529747746,"version":"4.9.1"},"reference-count":177,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Critically ill patients undergo early impairment of their gut microbiota (GM) due to routine antibiotic therapies and other environmental factors leading to intestinal dysbiosis. The GM establishes connections with the rest of the human body along several axes representing critical inter-organ crosstalks that, once disrupted, play a major role in the pathophysiology of numerous diseases and their complications. Key players in this communication are GM metabolites such as short-chain fatty acids and bile acids, neurotransmitters, hormones, interleukins, and toxins. Intensivists juggle at the crossroad of multiple connections between the intestine and the rest of the body. Harnessing the GM in ICU could improve the management of several challenges, such as infections, traumatic brain injury, heart failure, kidney injury, and liver dysfunction. The study of molecular pathways affected by the GM in different clinical conditions is still at an early stage, and evidence in critically ill patients is lacking. This review aims to describe dysbiosis in critical illness and provide intensivists with a perspective on the potential as adjuvant strategies (e.g., nutrition, probiotics, prebiotics and synbiotics supplementation, adsorbent charcoal, beta-lactamase, and fecal microbiota transplantation) to modulate the GM in ICU patients and attempt to restore eubiosis.<\/jats:p>","DOI":"10.1186\/s13054-022-04259-8","type":"journal-article","created":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T14:02:45Z","timestamp":1670421765000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["The central role of the gut in intensive care"],"prefix":"10.1186","volume":"26","author":[{"given":"Alberto","family":"Corriero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella Maria","family":"Gadaleta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filomena","family":"Puntillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Inchingolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Moschetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Brienza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,7]]},"reference":[{"issue":"8","key":"4259_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1002533","volume":"14","author":"R Sender","year":"2016","unstructured":"Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLOS Biol. 2016;14(8): e1002533.","journal-title":"PLOS Biol"},{"issue":"1","key":"4259_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13613-021-00976-5","volume":"12","author":"P Szychowiak","year":"2022","unstructured":"Szychowiak P, Villageois-Tran K, Patrier J, Timsit JF, Rupp\u00e9 \u00c9. The role of the microbiota in the management of intensive care patients. Ann Intensive Care. 2022;12(1):3.","journal-title":"Ann Intensive Care"},{"issue":"Suppl 1","key":"4259_CR3","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1111\/j.1753-4887.2012.00493.x","volume":"70","author":"LK Ursell","year":"2012","unstructured":"Ursell LK, Metcalf JL, Parfrey LW, Knight R. Defining the human microbiome. Nutr Rev. 2012;70(Suppl 1):S38-44.","journal-title":"Nutr Rev"},{"issue":"1","key":"4259_CR4","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13054-018-1999-8","volume":"22","author":"NS Wolff","year":"2018","unstructured":"Wolff NS, Hugenholtz F, Wiersinga WJ. The emerging role of the microbiota in the ICU. Crit Care. 2018;22(1):78.","journal-title":"Crit Care"},{"issue":"10","key":"4259_CR5","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.3390\/nu11102393","volume":"11","author":"E Rinninella","year":"2019","unstructured":"Rinninella E, Cintoni M, Raoul P, Lopetuso LR, Scaldaferri F, Pulcini G, et al. Food components and dietary habits: keys for a healthy gut microbiota composition. Nutrients. 2019;11(10):2393.","journal-title":"Nutrients"},{"issue":"5","key":"4259_CR6","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1111\/1574-6976.12075","volume":"38","author":"M Rajili\u0107-Stojanovi\u0107","year":"2014","unstructured":"Rajili\u0107-Stojanovi\u0107 M, de Vos WM. The first 1000 cultured species of the human gastrointestinal microbiota. FEMS Microbiol Rev. 2014;38(5):996\u20131047.","journal-title":"FEMS Microbiol Rev"},{"issue":"7","key":"4259_CR7","doi-asserted-by":"publisher","first-page":"4027","DOI":"10.3390\/ijms23074027","volume":"23","author":"AD Inchingolo","year":"2022","unstructured":"Inchingolo AD, Malcangi G, Inchingolo AM, Piras F, Settanni V, Garofoli G, et al. Benefits and implications of resveratrol supplementation on microbiota modulations: a systematic review of the literature. Int J Mol Sci. 2022;23(7):4027.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"4259_CR8","doi-asserted-by":"publisher","first-page":"6ra14","DOI":"10.1126\/scitranslmed.3000322","volume":"1","author":"PJ Turnbaugh","year":"2009","unstructured":"Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med. 2009;1(6):6ra14.","journal-title":"Sci Transl Med."},{"key":"4259_CR9","doi-asserted-by":"crossref","unstructured":"Stedtfeld RD, Chai B, Crawford RB, Stedtfeld TM, Williams MR, Xiangwen S, et al. Modulatory Influence of Segmented Filamentous Bacteria on Transcriptomic Response of Gnotobiotic Mice Exposed to TCDD. Front Microbiol [Internet]. 2017 [cited 2022 Oct 24];8. Available from: https:\/\/www.frontiersin.org\/articles\/\/10.3389\/fmicb.2017.01708","DOI":"10.3389\/fmicb.2017.01708"},{"issue":"3","key":"4259_CR10","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.cmet.2020.06.011","volume":"32","author":"H Wu","year":"2020","unstructured":"Wu H, Tremaroli V, Schmidt C, Lundqvist A, Olsson LM, Kr\u00e4mer M, et al. The Gut Microbiota in Prediabetes and Diabetes: A Population-Based Cross-Sectional Study. Cell Metab. 2020;32(3):379-390.e3.","journal-title":"Cell Metab"},{"issue":"2","key":"4259_CR11","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s11357-020-00188-y","volume":"43","author":"X Zhang","year":"2021","unstructured":"Zhang X, Yang Y, Su J, Zheng X, Wang C, Chen S, et al. Age-related compositional changes and correlations of gut microbiome, serum metabolome, and immune factor in rats. GeroScience. 2021;43(2):709\u201325.","journal-title":"GeroScience"},{"issue":"1","key":"4259_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3390\/futurepharmacol2010005","volume":"2","author":"V \u0158eho\u0159ov\u00e1","year":"2022","unstructured":"\u0158eho\u0159ov\u00e1 V, Cibulkov\u00e1 I, Soukupov\u00e1 H, Du\u0161ka F. Multi-donor fecal microbial transplantation for critically Ill patients: rationale and standard operating procedure. Future Pharmacol. 2022;2(1):55\u201363.","journal-title":"Future Pharmacol"},{"issue":"8","key":"4259_CR13","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1007\/s10620-011-1649-3","volume":"56","author":"M Hayakawa","year":"2011","unstructured":"Hayakawa M, Asahara T, Henzan N, Murakami H, Yamamoto H, Mukai N, et al. Dramatic changes of the gut flora immediately after severe and sudden insults. Dig Dis Sci. 2011;56(8):2361\u20135.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"4259_CR14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00134-016-4613-z","volume":"43","author":"JM Lankelma","year":"2017","unstructured":"Lankelma JM, van Vught LA, Belzer C, Schultz MJ, van der Poll T, de Vos WM, et al. Critically ill patients demonstrate large interpersonal variation in intestinal microbiota dysregulation: a pilot study. Intensive Care Med. 2017;43(1):59\u201368.","journal-title":"Intensive Care Med"},{"issue":"4","key":"4259_CR15","doi-asserted-by":"publisher","first-page":"0e00199","DOI":"10.1128\/mSphere.00199-16","volume":"1","author":"D McDonald","year":"2016","unstructured":"McDonald D, Ackermann G, Khailova L, Baird C, Heyland D, Kozar R, et al. Extreme dysbiosis of the microbiome in critical illness. mSphere. 2016;1(4):0e00199-16.","journal-title":"mSphere."},{"issue":"4","key":"4259_CR16","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/MCC.0000000000000321","volume":"22","author":"PE Wischmeyer","year":"2016","unstructured":"Wischmeyer PE, McDonald D, Knight R. Role of the microbiome, probiotics, and \u2018dysbiosis therapy\u2019 in critical illness. Curr Opin Crit Care. 2016;22(4):347\u201353.","journal-title":"Curr Opin Crit Care"},{"issue":"5","key":"4259_CR17","doi-asserted-by":"publisher","first-page":"e01361","DOI":"10.1128\/mBio.01361-14","volume":"5","author":"A Zaborin","year":"2014","unstructured":"Zaborin A, Smith D, Garfield K, Quensen J, Shakhsheer B, Kade M, et al. Membership and behavior of ultra-low-diversity pathogen communities present in the gut of humans during prolonged critical illness. MBio. 2014;5(5):e01361-e11314.","journal-title":"MBio"},{"issue":"43","key":"4259_CR18","doi-asserted-by":"publisher","first-page":"16731","DOI":"10.1073\/pnas.0804812105","volume":"105","author":"H Sokol","year":"2008","unstructured":"Sokol H, Pigneur B, Watterlot L, Lakhdari O, Berm\u00fadez-Humar\u00e1n LG, Gratadoux JJ, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A. 2008;105(43):16731\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"4259_CR19","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/SHK.0000000000000534","volume":"45","author":"MA Krezalek","year":"2016","unstructured":"Krezalek MA, DeFazio J, Zaborina O, Zaborin A, Alverdy JC. The shift of an intestinal \u201cmicrobiome\u201d to a \u201cpathobiome\u201d governs the course and outcome of sepsis following surgical injury. Shock Augusta Ga. 2016;45(5):475\u201382.","journal-title":"Shock Augusta Ga"},{"issue":"11","key":"4259_CR20","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/nri3535","volume":"13","author":"CG Buffie","year":"2013","unstructured":"Buffie CG, Pamer EG. Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol. 2013;13(11):790\u2013801.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"4259_CR21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S2213-2600(15)00427-0","volume":"4","author":"RP Dickson","year":"2016","unstructured":"Dickson RP. The microbiome and critical illness. Lancet Respir Med. 2016;4(1):59\u201372.","journal-title":"Lancet Respir Med"},{"key":"4259_CR22","doi-asserted-by":"crossref","unstructured":"Rutsch A, Kantsj\u00f6 JB, Ronchi F. The Gut-Brain Axis: How Microbiota and Host Inflammasome Influence Brain Physiology and Pathology. Front Immunol [Internet]. 2020 [cited 2022 Jul 12];11. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.604179","DOI":"10.3389\/fimmu.2020.604179"},{"issue":"6","key":"4259_CR23","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/pr.2015.51","volume":"77","author":"A P\u00e4rtty","year":"2015","unstructured":"P\u00e4rtty A, Kalliom\u00e4ki M, Wacklin P, Salminen S, Isolauri E. A possible link between early probiotic intervention and the risk of neuropsychiatric disorders later in childhood: a randomized trial. Pediatr Res. 2015;77(6):823\u20138.","journal-title":"Pediatr Res"},{"key":"4259_CR24","doi-asserted-by":"crossref","unstructured":"Ferrara M, Bertozzi G, Zanza C, Longhitano Y, Piccolella F, Lauritano CE, et al. Traumatic Brain Injury and Gut Brain Axis: The Disruption of an Alliance. Rev Recent Clin Trials. 2022 Jun 22;","DOI":"10.2174\/1574887117666220622143423"},{"issue":"1","key":"4259_CR25","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12974-022-02472-4","volume":"19","author":"VV Giridharan","year":"2022","unstructured":"Giridharan VV, Generoso JS, Lence L, Candiotto G, Streck E, Petronilho F, et al. A crosstalk between gut and brain in sepsis-induced cognitive decline. J Neuroinflammation. 2022;19(1):114.","journal-title":"J Neuroinflammation"},{"issue":"3","key":"4259_CR26","doi-asserted-by":"publisher","first-page":"e01399","DOI":"10.1128\/msystems.01399-21","volume":"7","author":"H Fang","year":"2022","unstructured":"Fang H, Wang Y, Deng J, Zhang H, Wu Q, He L, et al. Sepsis-induced gut dysbiosis mediates the susceptibility to sepsis-associated encephalopathy in mice. mSystems. 2022;7(3):e01399-e1421.","journal-title":"mSystems."},{"issue":"Pt 1","key":"4259_CR27","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1113\/jphysiol.2004.063388","volume":"558","author":"N Sudo","year":"2004","unstructured":"Sudo N, Chida Y, Aiba Y, Sonoda J, Oyama N, Yu XN, et al. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol. 2004;558(Pt 1):263\u201375.","journal-title":"J Physiol"},{"issue":"10","key":"4259_CR28","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.4249\/scholarpedia.4064","volume":"2","author":"JB Furness","year":"2007","unstructured":"Furness JB. Enteric nervous system. Scholarpedia. 2007;2(10):4064.","journal-title":"Scholarpedia"},{"issue":"2","key":"4259_CR29","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.cell.2015.02.047","volume":"161","author":"JM Yano","year":"2015","unstructured":"Yano JM, Yu K, Donaldson GP, Shastri GG, Ann P, Ma L, et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell. 2015;161(2):264\u201376.","journal-title":"Cell"},{"key":"4259_CR30","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1146\/annurev.med.60.042307.110802","volume":"60","author":"M Berger","year":"2009","unstructured":"Berger M, Gray JA, Roth BL. The expanded biology of serotonin. Annu Rev Med. 2009;60:355\u201366.","journal-title":"Annu Rev Med"},{"issue":"1","key":"4259_CR31","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/j.2042-7158.1959.tb12603.x","volume":"11","author":"V Erspamer","year":"1959","unstructured":"Erspamer V, Testini A. Observations on the release and turnover rate of 5-hydroxytryptamine in the gastrointestinal tract. J Pharm Pharmacol. 1959;11(1):618\u201323.","journal-title":"J Pharm Pharmacol"},{"issue":"2","key":"4259_CR32","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1113\/jphysiol.1960.sp006532","volume":"153","author":"G Bertaccini","year":"1960","unstructured":"Bertaccini G. Tissue 5-hydroxytryptamine and urinary 5-hydroxyindoleacetic acid after partial or total removal of the gastro-intestinal tract in the rat. J Physiol. 1960;153(2):239\u201349.","journal-title":"J Physiol"},{"key":"4259_CR33","doi-asserted-by":"crossref","unstructured":"Braniste V, Al-Asmakh M, Kowal C, Anuar F, Abbaspour A, T\u00f3th M, et al. The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med [Internet]. 2014 Nov 19 [cited 2022 Jul 14];6(263). Available from: https:\/\/www.science.org\/doi\/10.1126\/scitranslmed.3009759","DOI":"10.1126\/scitranslmed.3009759"},{"key":"4259_CR34","first-page":"30971","volume":"27","author":"AV Oleskin","year":"2016","unstructured":"Oleskin AV, Shenderov BA. Neuromodulatory effects and targets of the SCFAs and gasotransmitters produced by the human symbiotic microbiota. Microb Ecol Health Dis. 2016;27:30971.","journal-title":"Microb Ecol Health Dis"},{"issue":"6","key":"4259_CR35","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/mp.2016.46","volume":"21","author":"ML Wong","year":"2016","unstructured":"Wong ML, Inserra A, Lewis MD, Mastronardi CA, Leong L, Choo J, et al. Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition. Mol Psychiatry. 2016;21(6):797\u2013805.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"4259_CR36","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s12974-020-01944-9","volume":"17","author":"V Govindarajan","year":"2020","unstructured":"Govindarajan V, de Rivero Vaccari JP, Keane RW. Role of inflammasomes in multiple sclerosis and their potential as therapeutic targets. J Neuroinflammation. 2020;17(1):260.","journal-title":"J Neuroinflammation"},{"key":"4259_CR37","doi-asserted-by":"crossref","unstructured":"Bai H, Zhang Q. Activation of NLRP3 Inflammasome and Onset of Alzheimer\u2019s Disease. Front Immunol [Internet]. 2021 [cited 2022 Sep 13];12. Available from:https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.701282","DOI":"10.3389\/fimmu.2021.701282"},{"issue":"446","key":"4259_CR38","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.neuroscience.2020.08.004","volume":"15","author":"YQ Yan","year":"2020","unstructured":"Yan YQ, Fang Y, Zheng R, Pu JL, Zhang BR. NLRP3 inflammasomes in Parkinson\u2019s disease and their Regulation by Parkin. Neuroscience. 2020;15(446):323\u201334.","journal-title":"Neuroscience"},{"issue":"8","key":"4259_CR39","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.3390\/brainsci12081057","volume":"12","author":"Y Shen","year":"2022","unstructured":"Shen Y, Qian L, Luo H, Li X, Ruan Y, Fan R, et al. The significance of NLRP inflammasome in neuropsychiatric disorders. Brain Sci. 2022;12(8):1057.","journal-title":"Brain Sci"},{"issue":"8","key":"4259_CR40","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/PHM.0b013e3181aeab96","volume":"88","author":"IJ Baguley","year":"2009","unstructured":"Baguley IJ, Heriseanu RE, Nott MT, Chapman J, Sandanam J. Dysautonomia after severe traumatic brain injury: evidence of persisting overresponsiveness to afferent stimuli. Am J Phys Med Rehabil. 2009;88(8):615\u201322.","journal-title":"Am J Phys Med Rehabil"},{"issue":"6","key":"4259_CR41","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3748\/wjg.v10.i6.875","volume":"10","author":"CH Hang","year":"2004","unstructured":"Hang CH, Shi JX, Li JS, Wu W, Li WQ, Yin HX. Levels of vasoactive intestinal peptide, cholecystokinin and calcitonin gene-related peptide in plasma and jejunum of rats following traumatic brain injury and underlying significance in gastrointestinal dysfunction. World J Gastroenterol. 2004;10(6):875\u201380.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"4259_CR42","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.chom.2016.10.021","volume":"20","author":"AS Devlin","year":"2016","unstructured":"Devlin AS, Marcobal A, Dodd D, Nayfach S, Plummer N, Meyer T, et al. Modulation of a circulating uremic solute via rational genetic manipulation of the gut microbiota. Cell Host Microbe. 2016;20(6):709\u201315.","journal-title":"Cell Host Microbe"},{"issue":"1","key":"4259_CR43","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1146\/annurev-med-060513-093205","volume":"66","author":"JM Brown","year":"2015","unstructured":"Brown JM, Hazen SL. The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases. Annu Rev Med. 2015;66(1):343\u201359.","journal-title":"Annu Rev Med"},{"issue":"5","key":"4259_CR44","doi-asserted-by":"publisher","first-page":"663","DOI":"10.4070\/kcj.2017.0028","volume":"47","author":"T Kamo","year":"2017","unstructured":"Kamo T, Akazawa H, Suzuki JI, Komuro I. Novel Concept of a heart-gut axis in the pathophysiology of heart failure. Korean Circ J. 2017;47(5):663\u20139.","journal-title":"Korean Circ J."},{"issue":"16","key":"4259_CR45","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.jacc.2007.07.016","volume":"50","author":"A Sandek","year":"2007","unstructured":"Sandek A, Bauditz J, Swidsinski A, Buhner S, Weber-Eibel J, von Haehling S, et al. Altered intestinal function in patients with chronic heart failure. J Am Coll Cardiol. 2007;50(16):1561\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"4259_CR46","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.jacc.2014.06.1179","volume":"64","author":"A Sandek","year":"2014","unstructured":"Sandek A, Swidsinski A, Schroedl W, Watson A, Valentova M, Herrmann R, et al. Intestinal blood flow in patients with chronic heart failure: a link with bacterial growth, gastrointestinal symptoms, and cachexia. J Am Coll Cardiol. 2014;64(11):1092\u2013102.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"4259_CR47","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jchf.2015.10.009","volume":"4","author":"E Pasini","year":"2016","unstructured":"Pasini E, Aquilani R, Testa C, Baiardi P, Angioletti S, Boschi F, et al. Pathogenic gut flora in patients with chronic heart failure. JACC Heart Fail. 2016;4(3):220\u20137.","journal-title":"JACC Heart Fail"},{"issue":"10","key":"4259_CR48","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1681\/ASN.2014060543","volume":"26","author":"K Yang","year":"2015","unstructured":"Yang K, Wang C, Nie L, Zhao X, Gu J, Guan X, et al. Klotho protects against indoxyl sulphate-induced myocardial hypertrophy. J Am Soc Nephrol JASN. 2015;26(10):2434\u201346.","journal-title":"J Am Soc Nephrol JASN"},{"issue":"7341","key":"4259_CR49","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature09922","volume":"472","author":"Z Wang","year":"2011","unstructured":"Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472(7341):57\u201363.","journal-title":"Nature"},{"issue":"9","key":"4259_CR50","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.003698","volume":"5","author":"SH Karbach","year":"2016","unstructured":"Karbach SH, Sch\u00f6nfelder T, Brand\u00e3o I, Wilms E, H\u00f6rmann N, J\u00e4ckel S, et al. Gut microbiota promote angiotensin Ii\u2013induced arterial hypertension and vascular dysfunction. J Am Heart Assoc. 2016;5(9): e003698.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"4259_CR51","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1161\/CIRCHEARTFAILURE.113.000978","volume":"7","author":"XT Gan","year":"2014","unstructured":"Gan XT, Ettinger G, Huang CX, Burton JP, Haist JV, Rajapurohitam V, et al. Probiotic administration attenuates myocardial hypertrophy and heart failure after myocardial infarction in the rat. Circ Heart Fail. 2014;7(3):491\u20139.","journal-title":"Circ Heart Fail"},{"issue":"179","key":"4259_CR52","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.ijcard.2014.11.034","volume":"20","author":"AC Costanza","year":"2015","unstructured":"Costanza AC, Moscavitch SD, Faria Neto HCC, Mesquita ET. Probiotic therapy with Saccharomyces boulardii for heart failure patients: a randomized, double-blind, placebo-controlled pilot trial. Int J Cardiol. 2015;20(179):348\u201350.","journal-title":"Int J Cardiol"},{"key":"4259_CR53","unstructured":"Awoyemi A, Mayerhofer C, Felix AS, Hov JR, Moscavitch SD, Lappeg\u00e5rd KT, et al. Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial. eBioMedicine [Internet]. 2021 Aug 1 [cited 2022 Oct 23];70. Available from: https:\/\/www.thelancet.com\/journals\/ebiom\/article\/PIIS2352-3964(21)00304-2\/fulltext"},{"issue":"10","key":"4259_CR54","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1161\/CIRCULATIONAHA.116.024545","volume":"135","author":"FZ Marques","year":"2017","unstructured":"Marques FZ, Nelson E, Chu PY, Horlock D, Fiedler A, Ziemann M, et al. High-fiber diet and acetate supplementation change the gut microbiota and prevent the development of hypertension and heart failure in hypertensive mice. Circulation. 2017;135(10):964\u201377.","journal-title":"Circulation"},{"issue":"10","key":"4259_CR55","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.amjcard.2009.06.061","volume":"104","author":"EB Levitan","year":"2009","unstructured":"Levitan EB, Wolk A, Mittleman MA. Relation of consistency with the dietary approaches to stop hypertension diet and incidence of heart failure in men aged 45 to 79 years. Am J Cardiol. 2009;104(10):1416\u201320.","journal-title":"Am J Cardiol"},{"issue":"9","key":"4259_CR56","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/archinternmed.2009.56","volume":"169","author":"EB Levitan","year":"2009","unstructured":"Levitan EB, Wolk A, Mittleman MA. Consistency with the DASH diet and incidence of heart failure. Arch Intern Med. 2009;169(9):851\u20137.","journal-title":"Arch Intern Med"},{"issue":"2","key":"4259_CR57","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1080\/08998280.2015.11929216","volume":"28","author":"L Rifai","year":"2015","unstructured":"Rifai L, Pisano C, Hayden J, Sulo S, Silver MA. Impact of the DASH diet on endothelial function, exercise capacity, and quality of life in patients with heart failure. Proc Bayl Univ Med Cent. 2015;28(2):151\u20136.","journal-title":"Proc Bayl Univ Med Cent"},{"issue":"1","key":"4259_CR58","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.115.002314","volume":"9","author":"CL Organ","year":"2016","unstructured":"Organ CL, Otsuka H, Bhushan S, Wang Z, Bradley J, Trivedi R, et al. Choline diet and its gut microbe-derived metabolite, trimethylamine N-oxide, exacerbate pressure overload-induced heart failure. Circ Heart Fail. 2016;9(1): e002314.","journal-title":"Circ Heart Fail"},{"issue":"1","key":"4259_CR59","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1139\/f47-002","volume":"7","author":"FE Dyer","year":"1947","unstructured":"Dyer FE, Wood AJ. Action of enterobacteriaceae on choline and related compounds. J Fish Res Board Can. 1947;7(1):17\u201321.","journal-title":"J Fish Res Board Can"},{"key":"4259_CR60","doi-asserted-by":"publisher","first-page":"19076","DOI":"10.1038\/srep19076","volume":"6","author":"YM Chen","year":"2016","unstructured":"Chen YM, Liu Y, Zhou RF, Chen XL, Wang C, Tan XY, et al. Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults. Sci Rep. 2016;6:19076.","journal-title":"Sci Rep"},{"issue":"3","key":"4259_CR61","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1053\/j.gastro.2010.11.049","volume":"140","author":"MD Spencer","year":"2011","unstructured":"Spencer MD, Hamp TJ, Reid RW, Fischer LM, Zeisel SH, Fodor AA. Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency. Gastroenterology. 2011;140(3):976\u201386.","journal-title":"Gastroenterology"},{"issue":"8","key":"4259_CR62","doi-asserted-by":"publisher","first-page":"796","DOI":"10.5551\/jat.3285","volume":"17","author":"R Stepankova","year":"2010","unstructured":"Stepankova R, Tonar Z, Bartova J, Nedorost L, Rossman P, Poledne R, et al. Absence of microbiota (germ-free conditions) accelerates the atherosclerosis in ApoE-deficient mice fed standard low cholesterol diet. J Atheroscler Thromb. 2010;17(8):796\u2013804.","journal-title":"J Atheroscler Thromb"},{"issue":"24","key":"4259_CR63","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1161\/CIRCULATIONAHA.115.019645","volume":"133","author":"J Li","year":"2016","unstructured":"Li J, Lin S, Vanhoutte PM, Woo CW, Xu A. Akkermansia Muciniphila Protects against atherosclerosis by preventing metabolic endotoxemia-induced inflammation in Apoe \u2212\/\u2212 Mice. Circulation. 2016;133(24):2434\u201346.","journal-title":"Circulation"},{"issue":"10","key":"4259_CR64","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/nm.4176","volume":"22","author":"KE Fujimura","year":"2016","unstructured":"Fujimura KE, Sitarik AR, Havstad S, Lin DL, Levan S, Fadrosh D, et al. Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation. Nat Med. 2016;22(10):1187\u201391.","journal-title":"Nat Med"},{"issue":"5","key":"4259_CR65","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1111\/j.1572-0241.2001.03748.x","volume":"96","author":"A Yazar","year":"2001","unstructured":"Yazar A, Atis S, Konca K, Pata C, Akbay E, Calikoglu M, et al. Respiratory symptoms and pulmonary functional changes in patients with irritable bowel syndrome. Am J Gastroenterol. 2001;96(5):1511\u20136.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"4259_CR66","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1001\/archinte.1976.03630040056012","volume":"136","author":"SC Kraft","year":"1976","unstructured":"Kraft SC, Earle RH, Roesler M, Esterly JR. Unexplained bronchopulmonary disease with inflammatory bowel disease. Arch Intern Med. 1976;136(4):454\u20139.","journal-title":"Arch Intern Med"},{"issue":"2","key":"4259_CR67","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1155\/1999\/392575","volume":"6","author":"H Ward","year":"1999","unstructured":"Ward H, Fisher KL, Waghray R, Wright JL, Card SE, Cockcroft DW. Constrictive bronchiolitis and ulcerative colitis. Can Respir J. 1999;6(2):197\u2013200.","journal-title":"Can Respir J"},{"issue":"2","key":"4259_CR68","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/00054725-200303000-00004","volume":"9","author":"I Storch","year":"2003","unstructured":"Storch I, Sachar D, Katz S. Pulmonary manifestations of inflammatory bowel disease. Inflamm Bowel Dis. 2003;9(2):104\u201315.","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"4259_CR69","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1136\/thx.53.6.529","volume":"53","author":"TE Eaton","year":"1998","unstructured":"Eaton TE, Lambie N, Wells AU. Bronchiectasis following colectomy for Crohn\u2019s disease. Thorax. 1998;53(6):529\u201331.","journal-title":"Thorax"},{"issue":"7268","key":"4259_CR70","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1038\/nature08530","volume":"461","author":"KM Maslowski","year":"2009","unstructured":"Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D, et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature. 2009;461(7268):1282\u20136.","journal-title":"Nature"},{"issue":"2","key":"4259_CR71","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nm.3444","volume":"20","author":"A Trompette","year":"2014","unstructured":"Trompette A, Gollwitzer ES, Yadava K, Sichelstiel AK, Sprenger N, Ngom-Bru C, et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med. 2014;20(2):159\u201366.","journal-title":"Nat Med"},{"issue":"4","key":"4259_CR72","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1136\/gutjnl-2015-309728","volume":"65","author":"TJ Schuijt","year":"2016","unstructured":"Schuijt TJ, Lankelma JM, Scicluna BP, de Sousa e Melo F, Roelofs JJTH, de Boer JD, et al. The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia. Gut. 2016;65(4):575\u201383.","journal-title":"Gut"},{"issue":"1","key":"4259_CR73","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13054-022-03943-z","volume":"26","author":"S Mu","year":"2022","unstructured":"Mu S, Xiang H, Wang Y, Wei W, Long X, Han Y, et al. The pathogens of secondary infection in septic patients share a similar genotype to those that predominate in the gut. Crit Care Lond Engl. 2022;26(1):68.","journal-title":"Crit Care Lond Engl"},{"issue":"1","key":"4259_CR74","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12931-019-1203-y","volume":"20","author":"M Kyo","year":"2019","unstructured":"Kyo M, Nishioka K, Nakaya T, Kida Y, Tanabe Y, Ohshimo S, et al. Unique patterns of lower respiratory tract microbiota are associated with inflammation and hospital mortality in acute respiratory distress syndrome. Respir Res. 2019;20(1):246.","journal-title":"Respir Res"},{"issue":"1\u20134","key":"4259_CR75","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1159\/000363209","volume":"127","author":"S Noel","year":"2014","unstructured":"Noel S, Martina-Lingua MN, Bandapalle S, Pluznick J, Hamad ARA, Peterson DA, et al. Intestinal microbiota-kidney cross talk in acute kidney injury and chronic kidney disease. Nephron Clin Pract. 2014;127(1\u20134):139\u201343.","journal-title":"Nephron Clin Pract"},{"issue":"2","key":"4259_CR76","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1007\/s12602-018-9411-1","volume":"11","author":"NA Borges","year":"2019","unstructured":"Borges NA, Stenvinkel P, Bergman P, Qureshi AR, Lindholm B, Moraes C, et al. Effects of probiotic supplementation on trimethylamine-N-oxide plasma levels in hemodialysis patients: a pilot study. Probiotics Antimicrob Proteins. 2019;11(2):648\u201354.","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"1","key":"4259_CR77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141738","volume":"11","author":"C Missailidis","year":"2016","unstructured":"Missailidis C, H\u00e4llqvist J, Qureshi AR, Barany P, Heimb\u00fcrger O, Lindholm B, et al. Serum trimethylamine-N-oxide is strongly related to renal function and predicts outcome in chronic kidney disease. PLoS ONE. 2016;11(1): e0141738.","journal-title":"PLoS ONE"},{"issue":"3","key":"4259_CR78","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1159\/000360010","volume":"39","author":"J Wong","year":"2014","unstructured":"Wong J, Piceno YM, DeSantis TZ, Pahl M, Andersen GL, Vaziri ND. Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD. Am J Nephrol. 2014;39(3):230\u20137.","journal-title":"Am J Nephrol"},{"issue":"1","key":"4259_CR79","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12882-019-1668-4","volume":"21","author":"J Hu","year":"2020","unstructured":"Hu J, Zhong X, Yan J, Zhou D, Qin D, Xiao X, et al. High-throughput sequencing analysis of intestinal flora changes in ESRD and CKD patients. BMC Nephrol. 2020;21(1):12.","journal-title":"BMC Nephrol"},{"issue":"1","key":"4259_CR80","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12882-019-1238-9","volume":"20","author":"W Wang","year":"2019","unstructured":"Wang W, Hao G, Pan Y, Ma S, Yang T, Shi P, et al. Serum indoxyl sulfate is associated with mortality in hospital-acquired acute kidney injury: a prospective cohort study. BMC Nephrol. 2019;20(1):57.","journal-title":"BMC Nephrol"},{"issue":"11","key":"4259_CR81","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.1073\/pnas.1215927110","volume":"110","author":"JL Pluznick","year":"2013","unstructured":"Pluznick JL, Protzko RJ, Gevorgyan H, Peterlin Z, Sipos A, Han J, et al. Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. Proc Natl Acad Sci. 2013;110(11):4410\u20135.","journal-title":"Proc Natl Acad Sci"},{"issue":"11","key":"4259_CR82","first-page":"11894","volume":"33","author":"RJF Felizardo","year":"2019","unstructured":"Felizardo RJF, de Almeida DC, Pereira RL, Watanabe IKM, Doimo NTS, Ribeiro WR, et al. Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic- and GPR109a-mediated mechanisms. FASEB J Off Publ Fed Am Soc Exp Biol. 2019;33(11):11894\u2013908.","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"issue":"8","key":"4259_CR83","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1681\/ASN.2014030288","volume":"26","author":"V Andrade-Oliveira","year":"2015","unstructured":"Andrade-Oliveira V, Amano MT, Correa-Costa M, Castoldi A, Felizardo RJF, de Almeida DC, et al. Gut bacteria products prevent AKI induced by ischemia-reperfusion. J Am Soc Nephrol JASN. 2015;26(8):1877\u201388.","journal-title":"J Am Soc Nephrol JASN"},{"issue":"4","key":"4259_CR84","doi-asserted-by":"publisher","first-page":"620","DOI":"10.23876\/j.krcp.20.265","volume":"40","author":"J Yang","year":"2021","unstructured":"Yang J, Ji GE, Park MS, Seong YJ, Go YS, Lee HY, et al. Probiotics partially attenuate the severity of acute kidney injury through an immunomodulatory effect. Kidney Res Clin Pract. 2021;40(4):620\u201333.","journal-title":"Kidney Res Clin Pract"},{"issue":"20","key":"4259_CR85","doi-asserted-by":"publisher","first-page":"e97957","DOI":"10.1172\/jci.insight.97957","volume":"3","author":"Y Nakade","year":"2018","unstructured":"Nakade Y, Iwata Y, Furuichi K, Mita M, Hamase K, Konno R, et al. Gut microbiota\u2013derived D-serine protects against acute kidney injury. JCI Insight. 2018;3(20):e97957.","journal-title":"JCI Insight."},{"issue":"9","key":"4259_CR86","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1096\/fj.13-231860","volume":"27","author":"G Xie","year":"2013","unstructured":"Xie G, Zhong W, Li H, Li Q, Qiu Y, Zheng X, et al. Alteration of bile acid metabolism in the rat induced by chronic ethanol consumption. FASEB J. 2013;27(9):3583\u201393.","journal-title":"FASEB J"},{"issue":"12","key":"4259_CR87","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1111\/acer.12900","volume":"39","author":"P Chen","year":"2015","unstructured":"Chen P, Miyamoto Y, Mazagova M, Lee KC, Eckmann L, Schnabl B. Microbiota protects mice against acute alcohol-induced liver injury. Alcohol Clin Exp Res. 2015;39(12):2313\u201323.","journal-title":"Alcohol Clin Exp Res"},{"issue":"7","key":"4259_CR88","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1021\/pr400362z","volume":"12","author":"G Xie","year":"2013","unstructured":"Xie G, Zhong W, Zheng X, Li Q, Qiu Y, Li H, et al. Chronic Ethanol consumption alters mammalian gastrointestinal content metabolites. J Proteome Res. 2013;12(7):3297\u2013306.","journal-title":"J Proteome Res"},{"issue":"7783","key":"4259_CR89","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41586-019-1742-x","volume":"575","author":"Y Duan","year":"2019","unstructured":"Duan Y, Llorente C, Lang S, Brandl K, Chu H, Jiang L, et al. Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease. Nature. 2019;575(7783):505\u201311.","journal-title":"Nature"},{"issue":"4","key":"4259_CR90","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.cmet.2019.08.018","volume":"30","author":"J Yuan","year":"2019","unstructured":"Yuan J, Chen C, Cui J, Lu J, Yan C, Wei X, et al. Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella pneumoniae. Cell Metab. 2019;30(4):675-688.e7.","journal-title":"Cell Metab"},{"issue":"6380","key":"4259_CR91","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1126\/science.aar7201","volume":"359","author":"S Manfredo Vieira","year":"2018","unstructured":"Manfredo Vieira S, Hiltensperger M, Kumar V, Zegarra-Ruiz D, Dehner C, Khan N, et al. Translocation of a gut pathobiont drives autoimmunity in mice and humans. Science. 2018;359(6380):1156\u201361.","journal-title":"Science"},{"issue":"30","key":"4259_CR92","doi-asserted-by":"publisher","first-page":"18017","DOI":"10.1074\/jbc.271.30.18017","volume":"271","author":"S Ishibashi","year":"1996","unstructured":"Ishibashi S, Schwarz M, Frykman PK, Herz J, Russell DW. Disruption of cholesterol 7alpha-hydroxylase gene in mice. I. Postnatal lethality reversed by bile acid and vitamin supplementation. J Biol Chem. 1996;271(30):18017\u201323.","journal-title":"J Biol Chem"},{"issue":"4","key":"4259_CR93","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1210\/jc.2002-021580","volume":"88","author":"JB Cheng","year":"2003","unstructured":"Cheng JB, Jacquemin E, Gerhardt M, Nazer H, Cresteil D, Heubi JE, et al. Molecular genetics of 3beta-hydroxy-Delta5-C27-steroid oxidoreductase deficiency in 16 patients with loss of bile acid synthesis and liver disease. J Clin Endocrinol Metab. 2003;88(4):1833\u201341.","journal-title":"J Clin Endocrinol Metab"},{"issue":"15","key":"4259_CR94","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.3390\/nu14153212","volume":"14","author":"RM Gadaleta","year":"2022","unstructured":"Gadaleta RM, Cariello M, Crudele L, Moschetta A. Bile salt hydrolase-competent probiotics in the management of IBD: unlocking the \u2018Bile Acid Code.\u2019 Nutrients. 2022;14(15):3212.","journal-title":"Nutrients"},{"issue":"6","key":"4259_CR95","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.jhep.2017.01.005","volume":"66","author":"A Filliol","year":"2017","unstructured":"Filliol A, Piquet-Pellorce C, Ragu\u00e9n\u00e8s-Nicol C, Dion S, Farooq M, Lucas-Clerc C, et al. RIPK1 protects hepatocytes from Kupffer cells-mediated TNF-induced apoptosis in mouse models of PAMP-induced hepatitis. J Hepatol. 2017;66(6):1205\u201313.","journal-title":"J Hepatol"},{"key":"4259_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113380","volume":"153","author":"M Marzano","year":"2022","unstructured":"Marzano M, Fosso B, Colliva C, Notario E, Passeri D, Intranuovo M, et al. Farnesoid X receptor activation by the novel agonist TC-100 (3\u03b1, 7\u03b1, 11\u03b2-Trihydroxy-6\u03b1-ethyl-5\u03b2-cholan-24-oic Acid) preserves the intestinal barrier integrity and promotes intestinal microbial reshaping in a mouse model of obstructed bile acid flow. Biomed Pharmacother Biomed Pharmacother. 2022;153: 113380.","journal-title":"Biomed Pharmacother Biomed Pharmacother"},{"key":"4259_CR97","doi-asserted-by":"crossref","unstructured":"Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease | Gut [Internet]. [cited 2022 Aug 28]. Available from: https:\/\/gut.bmj.com\/content\/67\/5\/891","DOI":"10.1136\/gutjnl-2016-313432"},{"issue":"16","key":"4259_CR98","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.3390\/jcm10163578","volume":"10","author":"H Kang","year":"2021","unstructured":"Kang H, Thomas RM. Bacteria and sepsis: microbiome to the rescue? J Clin Med. 2021;10(16):3578.","journal-title":"J Clin Med"},{"issue":"2","key":"4259_CR99","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00134-005-0023-3","volume":"32","author":"N Brienza","year":"2006","unstructured":"Brienza N, Dalfino L, Cinnella G, Diele C, Bruno F, Fiore T. Jaundice in critical illness: promoting factors of a concealed reality. Intensive Care Med. 2006;32(2):267\u201374.","journal-title":"Intensive Care Med"},{"issue":"9","key":"4259_CR100","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1111\/jgh.13731","volume":"32","author":"GA Cresci","year":"2017","unstructured":"Cresci GA, Glueck B, McMullen MR, Xin W, Allende D, Nagy LE. Prophylactic tributyrin treatment mitigates chronic-binge ethanol-induced intestinal barrier and liver injury. J Gastroenterol Hepatol. 2017;32(9):1587\u201397.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"4259_CR101","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1053\/j.gastro.2014.09.014","volume":"148","author":"P Chen","year":"2015","unstructured":"Chen P, Torralba M, Tan J, Embree M, Zengler K, St\u00e4rkel P, et al. Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice. Gastroenterology. 2015;148(1):203-214.e16.","journal-title":"Gastroenterology"},{"issue":"9","key":"4259_CR102","doi-asserted-by":"publisher","first-page":"5398","DOI":"10.1038\/s41598-019-41738-5","volume":"1","author":"R Mart\u00edn","year":"2019","unstructured":"Mart\u00edn R, Chamignon C, Mhedbi-Hajri N, Chain F, Derrien M, Escribano-V\u00e1zquez U, et al. The potential probiotic Lactobacillus rhamnosus CNCM I-3690 strain protects the intestinal barrier by stimulating both mucus production and cytoprotective response. Sci Rep. 2019;1(9):5398.","journal-title":"Sci Rep"},{"issue":"4","key":"4259_CR103","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/apha.12695","volume":"217","author":"D Ahl","year":"2016","unstructured":"Ahl D, Liu H, Schreiber O, Roos S, Phillipson M, Holm L. Lactobacillus reuteri increases mucus thickness and ameliorates dextran sulphate sodium-induced colitis in mice. Acta Physiol. 2016;217(4):300\u201310.","journal-title":"Acta Physiol"},{"issue":"1","key":"4259_CR104","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0261-5614(93)90143-R","volume":"12","author":"AL Buchman","year":"1993","unstructured":"Buchman AL, Moukarzel A, Jenden DJ, Roch M, Rice K, Ament ME. Low plasma free choline is prevalent in patients receiving long term parenteral nutrition and is associated with hepatic aminotransferase abnormalities. Clin Nutr Edinb Scotl. 1993;12(1):33\u20137.","journal-title":"Clin Nutr Edinb Scotl"},{"issue":"5","key":"4259_CR105","first-page":"1399","volume":"22","author":"AL Buchman","year":"1995","unstructured":"Buchman AL, Dubin MD, Moukarzel AA, Jenden DJ, Roch M, Rice KM, et al. Choline deficiency: a cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation. Hepatol Baltim Md. 1995;22(5):1399\u2013403.","journal-title":"Hepatol Baltim Md"},{"issue":"1","key":"4259_CR106","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1590\/S0004-28032011000100015","volume":"48","author":"E Marcolin","year":"2011","unstructured":"Marcolin E, Forgiarini LF, Tieppo J, Dias AS, de Freitas LAR, Marroni NP. Methionine- and choline-deficient diet induces hepatic changes characteristic of non-alcoholic steatohepatitis. Arq Gastroenterol. 2011;48(1):72\u20139.","journal-title":"Arq Gastroenterol"},{"issue":"10","key":"4259_CR107","first-page":"2371","volume":"41","author":"JL Flores-Guerrero","year":"2021","unstructured":"Flores-Guerrero JL, Post A, van Dijk PR, Connelly MA, Garcia E, Navis G, et al. Circulating trimethylamine-N-oxide is associated with all-cause mortality in subjects with nonalcoholic fatty liver disease. Liver Int Off J Int Assoc Study Liver. 2021;41(10):2371\u201382.","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"issue":"17","key":"4259_CR108","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201900257","volume":"63","author":"X Tan","year":"2019","unstructured":"Tan X, Liu Y, Long J, Chen S, Liao G, Wu S, et al. Trimethylamine N-oxide aggravates liver steatosis through modulation of bile acid metabolism and inhibition of farnesoid X receptor signaling in nonalcoholic fatty liver disease. Mol Nutr Food Res. 2019;63(17): e1900257.","journal-title":"Mol Nutr Food Res"},{"issue":"1","key":"4259_CR109","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.accpm.2019.06.014","volume":"39","author":"C Paugam-Burtz","year":"2020","unstructured":"Paugam-Burtz C, Levesque E, Louvet A, Thabut D, Amathieu R, Bureau C, et al. Management of liver failure in general intensive care unit. Anaesth Crit Care Pain Med. 2020;39(1):143\u201361.","journal-title":"Anaesth Crit Care Pain Med"},{"issue":"3","key":"4259_CR110","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/MPG.0000000000001422","volume":"64","author":"F Famouri","year":"2017","unstructured":"Famouri F, Shariat Z, Hashemipour M, Keikha M, Kelishadi R. Effects of probiotics on nonalcoholic fatty liver disease in obese children and adolescents. J Pediatr Gastroenterol Nutr. 2017;64(3):413\u20137.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"4259_CR111","doi-asserted-by":"crossref","unstructured":"Xue L, Deng Z, Luo W, He X, Chen Y. Effect of Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial. Front Cell Infect Microbiol [Internet]. 2022 [cited 2022 Oct 25];12. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.759306","DOI":"10.3389\/fcimb.2022.759306"},{"key":"4259_CR112","unstructured":"Effects of probiotics (cultured Lactobacillus subtilis\/Streptococcus faecium) in the treatment of alcoholic hepatitis: randomized-controlled multicenter study - PubMed [Internet]. [cited 2022 Aug 28]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26302024\/"},{"issue":"1","key":"4259_CR113","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13054-016-1298-1","volume":"20","author":"G Elke","year":"2016","unstructured":"Elke G, van Zanten ARH, Lemieux M, McCall M, Jeejeebhoy KN, Kott M, et al. Enteral versus parenteral nutrition in critically ill patients: an updated systematic review and meta-analysis of randomized controlled trials. Crit Care. 2016;20(1):117.","journal-title":"Crit Care"},{"issue":"10","key":"4259_CR114","doi-asserted-by":"publisher","first-page":"e00543","DOI":"10.1128\/AAC.00543-17","volume":"61","author":"C Burdet","year":"2017","unstructured":"Burdet C, Sayah-Jeanne S, Nguyen TT, Miossec C, Saint-Lu N, Pulse M, et al. Protection of hamsters from mortality by reducing fecal moxifloxacin concentration with DAV131A in a model of moxifloxacin-induced clostridium difficile colitis. Antimicrob Agents Chemother. 2017;61(10):e00543-e617.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"4259_CR115","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1093\/jac\/dkab474","volume":"77","author":"MJGT Vehreschild","year":"2022","unstructured":"Vehreschild MJGT, Ducher A, Louie T, Cornely OA, Feger C, Dane A, et al. An open randomized multicentre Phase 2 trial to assess the safety of DAV132 and its efficacy to protect gut microbiota diversity in hospitalized patients treated with fluoroquinolones. J Antimicrob Chemother. 2022;77(4):1155\u201365.","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"4259_CR116","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.3390\/nu14081600","volume":"14","author":"HA Cheema","year":"2022","unstructured":"Cheema HA, Shahid A, Ayyan M, Mustafa B, Zahid A, Fatima M, et al. Probiotics for the prevention of ventilator-associated pneumonia: an updated systematic review and meta-analysis of randomised controlled trials. Nutrients. 2022;14(8):1600.","journal-title":"Nutrients"},{"key":"4259_CR117","doi-asserted-by":"crossref","unstructured":"Li C, Lu F, Chen J, Ma J, Xu N. Probiotic supplementation prevents the development of ventilator-associated pneumonia for mechanically ventilated ICU patients: a systematic review and network meta-analysis of randomized controlled trials. Front Nutr [Internet]. 2022 [cited 2022 Jul 29];9. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2022.919156","DOI":"10.3389\/fnut.2022.919156"},{"issue":"19","key":"4259_CR118","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s13054-016-1434-y","volume":"19","author":"W Manzanares","year":"2016","unstructured":"Manzanares W, Lemieux M, Langlois PL, Wischmeyer PE. Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis. Crit Care Lond Engl. 2016;19(19):262.","journal-title":"Crit Care Lond Engl"},{"issue":"3","key":"4259_CR119","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1136\/gutjnl-2014-307649","volume":"65","author":"E Qu\u00e9vrain","year":"2016","unstructured":"Qu\u00e9vrain E, Maubert MA, Michon C, Chain F, Marquant R, Tailhades J, et al. Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn\u2019s disease. Gut. 2016;65(3):415\u201325.","journal-title":"Gut"},{"issue":"1","key":"4259_CR120","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1097\/ALN.0b013e318291c2fc","volume":"119","author":"L Khailova","year":"2013","unstructured":"Khailova L, Frank DN, Dominguez JA, Wischmeyer PE. Probiotic administration reduces mortality and improves intestinal epithelial homeostasis in experimental sepsis. Anesthesiology. 2013;119(1):166\u201377.","journal-title":"Anesthesiology"},{"key":"4259_CR121","unstructured":"Biosearch SA. Multicentric Study to Assess the Effect of Consumption of Lactobacillus Coryniformis K8 on Healthcare Personnel Exposed to COVID-19 [Internet]. clinicaltrials.gov; 2020 Apr [cited 2022 Aug 28]. Report No.: NCT04366180. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04366180"},{"key":"4259_CR122","unstructured":"\u00d6rebro University, Sweden. Exploratory Study on the Effects of Probiotic Supplementation on SARS-CoV-2 Antibody Response in Healthy Adults [Internet]. clinicaltrials.gov; 2021 Oct [cited 2022 Aug 28]. Report No.: NCT04734886. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04734886"},{"key":"4259_CR123","unstructured":"Duke University. A Randomized Trial of the Effect of Lactobacillus on the Microbiome of Household Contacts Exposed to COVID-19 [Internet]. clinicaltrials.gov; 2022 Feb [cited 2022 Aug 28]. Report No.: NCT04399252. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04399252"},{"key":"4259_CR124","unstructured":"I.M. Sechenov First Moscow State Medical University. Efficacy of Probiotics (Lactobacillus Rhamnosus, Bifidobacterium Bifidum, Bifidobacterium Longum Subsp. Infantis and Bifidobacterium Longum) in the Treatment of Hospitalised Patients With Novel Coronavirus Infection [Internet]. clinicaltrials.gov; 2022 Jan [cited 2022 Aug 28]. Report No.: NCT04854941. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04854941"},{"key":"4259_CR125","unstructured":"Centre hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM). Randomised Single Blinded Clinical Study of Efficacy of Intranasal Probiotic Treatment to Reduce Severity of Symptoms in COVID19 Infection [Internet]. clinicaltrials.gov; 2021 May [cited 2022 Aug 28]. Report No.: NCT04458519. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04458519"},{"key":"4259_CR126","unstructured":"AB Biotics, SA. Efficacy and Safety of Lactobacillus Plantarum and Pediococcus Acidilactici as Co-adjuvant Therapy for Reducing the Risk of Severe Disease in Adults With SARS-CoV-2 and Its Modulation of the Fecal Microbiota: A Randomized Clinical Trial [Internet]. clinicaltrials.gov; 2021 May [cited 2022 Aug 28]. Report No.: NCT04517422. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04517422"},{"issue":"12","key":"4259_CR127","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1084\/jem.20151345","volume":"213","author":"KA Kigerl","year":"2016","unstructured":"Kigerl KA, Hall JCE, Wang L, Mo X, Yu Z, Popovich PG. Gut dysbiosis impairs recovery after spinal cord injury. J Exp Med. 2016;213(12):2603\u201320.","journal-title":"J Exp Med"},{"issue":"3","key":"4259_CR128","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1056\/NEJMoa2106516","volume":"386","author":"P Feuerstadt","year":"2022","unstructured":"Feuerstadt P, Louie TJ, Lashner B, Wang EEL, Diao L, Bryant JA, et al. SER-109, an oral microbiome therapy for recurrent clostridioides difficile infection. N Engl J Med. 2022;386(3):220\u20139.","journal-title":"N Engl J Med"},{"key":"4259_CR129","doi-asserted-by":"crossref","unstructured":"Kokai-Kun J, Connelly S. Ribaxamase, an orally administered \u03b2-lactamase, protects the gut microbiome in patients treated with ceftriaxone. J Transl Sci [Internet]. 2020 [cited 2022 Aug 30];6(3). Available from: https:\/\/www.oatext.com\/ribaxamase-an-orally-administered-v-lactamase-protects-the-gut-microbiome-in-patients-treated-with-ceftriaxone.php#gsc.tab=0","DOI":"10.15761\/JTS.1000344"},{"key":"4259_CR130","unstructured":"Synthetic Biologics Inc. Phase 1b\/2a Evaluation of the Safety and Tolerability of SYN-004 in Adult Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Recipients [Internet]. clinicaltrials.gov; 2022 Apr [cited 2022 Oct 24]. Report No.: NCT04692181. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04692181"},{"issue":"5","key":"4259_CR131","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/apt.14201","volume":"46","author":"MN Quraishi","year":"2017","unstructured":"Quraishi MN, Widlak M, Bhala N, Moore D, Price M, Sharma N, et al. Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection. Aliment Pharmacol Ther. 2017;46(5):479\u201393.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"4259_CR132","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1136\/gutjnl-2016-313017","volume":"66","author":"G Cammarota","year":"2017","unstructured":"Cammarota G, Ianiro G, Tilg H, Rajili\u0107-Stojanovi\u0107 M, Kump P, Satokari R, et al. European consensus conference on faecal microbiota transplantation in clinical practice. Gut. 2017;66(4):569\u201380.","journal-title":"Gut"},{"issue":"2","key":"4259_CR133","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/apt.14816","volume":"48","author":"G Ianiro","year":"2018","unstructured":"Ianiro G, Masucci L, Quaranta G, Simonelli C, Lopetuso LR, Sanguinetti M, et al. Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection\u2014single versus multiple infusions. Aliment Pharmacol Ther. 2018;48(2):152\u20139.","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"4259_CR134","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1016\/j.cgh.2019.12.029","volume":"18","author":"YW Cheng","year":"2020","unstructured":"Cheng YW, Phelps E, Nemes S, Rogers N, Sagi S, Bohm M, et al. Fecal microbiota transplant decreases mortality in patients with refractory severe or fulminant clostridioides difficile infection. Clin Gastroenterol Hepatol. 2020;18(10):2234-2243.e1.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4259_CR135","first-page":"S48","volume":"112","author":"YW Cheng","year":"2017","unstructured":"Cheng YW, Xu H, Phelps E, Rogers N, Sagi S, Bohm M, et al. Fecal microbiota transplant decreases mortality in patients with refractory severe and severe complicatedclostridium difficileinfection not eligible for colectomy: 2017 fellows-in-training award (Colon Category): 100. Off J Am Coll Gastroenterol ACG. 2017;112:S48.","journal-title":"Off J Am Coll Gastroenterol ACG"},{"issue":"3","key":"4259_CR136","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1080\/19490976.2016.1273998","volume":"8","author":"M Fischer","year":"2017","unstructured":"Fischer M, Sipe B, Cheng YW, Phelps E, Rogers N, Sagi S, et al. Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: a promising treatment approach. Gut Microbes. 2017;8(3):289\u2013302.","journal-title":"Gut Microbes"},{"issue":"5","key":"4259_CR137","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1093\/cid\/cix762","volume":"66","author":"M Hocquart","year":"2018","unstructured":"Hocquart M, Lagier JC, Cassir N, Saidani N, Eldin C, Kerbaj J, et al. Early fecal microbiota transplantation improves survival in severe clostridium difficile infections. Clin Infect Dis. 2018;66(5):645\u201350.","journal-title":"Clin Infect Dis"},{"key":"4259_CR138","doi-asserted-by":"publisher","first-page":"5816837","DOI":"10.1155\/2021\/5816837","volume":"2021","author":"D Du","year":"2021","unstructured":"Du D, Tang W, Zhou C, Sun X, Wei Z, Zhong J, et al. Fecal microbiota transplantation is a promising method to restore gut microbiota dysbiosis and relieve neurological deficits after traumatic brain injury. Oxid Med Cell Longev. 2021;2021:5816837.","journal-title":"Oxid Med Cell Longev"},{"issue":"11","key":"4259_CR139","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1038\/ajg.2014.299","volume":"109","author":"Q Li","year":"2014","unstructured":"Li Q, Wang C, Tang C, He Q, Zhao X, Li N, et al. Therapeutic modulation and reestablishment of the intestinal microbiota with fecal microbiota transplantation resolves sepsis and diarrhea in a patient. Am J Gastroenterol. 2014;109(11):1832\u20134.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"4259_CR140","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s13054-016-1491-2","volume":"20","author":"Y Wei","year":"2016","unstructured":"Wei Y, Yang J, Wang J, Yang Y, Huang J, Gong H, et al. Successful treatment with fecal microbiota transplantation in patients with multiple organ dysfunction syndrome and diarrhea following severe sepsis. Crit Care Lond Engl. 2016;20(1):332.","journal-title":"Crit Care Lond Engl"},{"issue":"5","key":"4259_CR141","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.3945\/ajcn.117.156380","volume":"106","author":"JL Kaczmarek","year":"2017","unstructured":"Kaczmarek JL, Musaad SM, Holscher HD. Time of day and eating behaviors are associated with the composition and function of the human gastrointestinal microbiota. Am J Clin Nutr. 2017;106(5):1220\u201331.","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"4259_CR142","doi-asserted-by":"publisher","first-page":"R1254","DOI":"10.1152\/ajpregu.00037.2018","volume":"315","author":"E Klingbeil","year":"2018","unstructured":"Klingbeil E, de La Serre CB. Microbiota modulation by eating patterns and diet composition: impact on food intake. Am J Physiol Regul Integr Comp Physiol. 2018;315(6):R1254\u201360.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"2","key":"4259_CR143","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/MCC.0000000000000582","volume":"25","author":"T Oami","year":"2019","unstructured":"Oami T, Chihade DB, Coopersmith CM. The microbiome and nutrition in critical illness. Curr Opin Crit Care. 2019;25(2):145\u20139.","journal-title":"Curr Opin Crit Care"},{"issue":"10","key":"4259_CR144","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1007\/s00134-009-1567-4","volume":"35","author":"C Alberda","year":"2009","unstructured":"Alberda C, Gramlich L, Jones N, Jeejeebhoy K, Day AG, Dhaliwal R, et al. The relationship between nutritional intake and clinical outcomes in critically ill patients: results of an international multicenter observational study. Intensive Care Med. 2009;35(10):1728\u201337.","journal-title":"Intensive Care Med"},{"issue":"8","key":"4259_CR145","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.3390\/nu4081095","volume":"4","author":"K Brown","year":"2012","unstructured":"Brown K, DeCoffe D, Molcan E, Gibson DL. Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients. 2012;4(8):1095\u2013119.","journal-title":"Nutrients"},{"issue":"8","key":"4259_CR146","doi-asserted-by":"publisher","first-page":"6294","DOI":"10.3390\/nu7085288","volume":"7","author":"X Wan","year":"2015","unstructured":"Wan X, Bi J, Gao X, Tian F, Wang X, Li N, et al. Partial enteral nutrition preserves elements of gut barrier function, including innate immunity, intestinal alkaline phosphatase (IAP) level, and intestinal microbiota in mice. Nutrients. 2015;7(8):6294\u2013312.","journal-title":"Nutrients"},{"issue":"6052","key":"4259_CR147","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1126\/science.1208344","volume":"334","author":"GD Wu","year":"2011","unstructured":"Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, et al. Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011;334(6052):105\u20138.","journal-title":"Science"},{"issue":"361","key":"4259_CR148","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k2179","volume":"13","author":"AM Valdes","year":"2018","unstructured":"Valdes AM, Walter J, Segal E, Spector TD. Role of the gut microbiota in nutrition and health. BMJ. 2018;13(361): k2179.","journal-title":"BMJ"},{"issue":"1","key":"4259_CR149","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.clnu.2018.08.037","volume":"38","author":"P Singer","year":"2019","unstructured":"Singer P, Blaser AR, Berger MM, Alhazzani W, Calder PC, Casaer MP, et al. ESPEN guideline on clinical nutrition in the intensive care unit. Clin Nutr. 2019;38(1):48\u201379.","journal-title":"Clin Nutr"},{"issue":"7541","key":"4259_CR150","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature14232","volume":"519","author":"B Chassaing","year":"2015","unstructured":"Chassaing B, Koren O, Goodrich JK, Poole AC, Srinivasan S, Ley RE, et al. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature. 2015;519(7541):92\u20136.","journal-title":"Nature"},{"issue":"12","key":"4259_CR151","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.3390\/nu11123002","volume":"11","author":"R Moron","year":"2019","unstructured":"Moron R, Galvez J, Colmenero M, Anderson P, Cabeza J, Rodriguez-Cabezas ME. The importance of the microbiome in critically ill patients: role of nutrition. Nutrients. 2019;11(12):3002.","journal-title":"Nutrients"},{"issue":"8","key":"4259_CR152","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","volume":"11","author":"C Hill","year":"2014","unstructured":"Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506\u201314.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"4259_CR153","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/1475-2891-10-138","volume":"10","author":"J Kabeerdoss","year":"2011","unstructured":"Kabeerdoss J, Devi RS, Mary RR, Prabhavathi D, Vidya R, Mechenro J, et al. Effect of yoghurt containing Bifidobacterium lactis Bb12\u00aeon faecal excretion of secretory immunoglobulin A and human beta-defensin 2 in healthy adult volunteers. Nutr J. 2011;10(1):138.","journal-title":"Nutr J"},{"issue":"3","key":"4259_CR154","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/j.1365-2249.2007.03587.x","volume":"151","author":"M Schlee","year":"2008","unstructured":"Schlee M, Harder J, K\u00f6ten B, Stange EF, Wehkamp J, Fellermann K. Probiotic lactobacilli and VSL#3 induce enterocyte \u03b2-defensin 2. Clin Exp Immunol. 2008;151(3):528\u201335.","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"4259_CR155","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/mi.2008.77","volume":"2","author":"M M\u00f6ndel","year":"2009","unstructured":"M\u00f6ndel M, Schroeder BO, Zimmermann K, Huber H, Nuding S, Beisner J, et al. Probiotic E. coli treatment mediates antimicrobial human \u03b2-defensin synthesis and fecal excretion in humans. Mucosal Immunol. 2009;2(2):166\u201372.","journal-title":"Mucosal Immunol"},{"issue":"11","key":"4259_CR156","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1001\/jama.2021.13355","volume":"326","author":"J Johnstone","year":"2021","unstructured":"Johnstone J, Meade M, Lauzier F, Marshall J, Duan E, Dionne J, et al. Effect of probiotics on incident ventilator-associated pneumonia in critically ill patients: a randomized clinical trial. JAMA. 2021;326(11):1024\u201333.","journal-title":"JAMA"},{"issue":"1","key":"4259_CR157","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2021.106471","volume":"59","author":"M Tsilika","year":"2022","unstructured":"Tsilika M, Thoma G, Aidoni Z, Tsaousi G, Fotiadis K, Stavrou G, et al. A four-probiotic preparation for ventilator-associated pneumonia in multi-trauma patients: results of a randomized clinical trial. Int J Antimicrob Agents. 2022;59(1): 106471.","journal-title":"Int J Antimicrob Agents"},{"key":"4259_CR158","first-page":"1","volume":"16","author":"SH Lan","year":"2022","unstructured":"Lan SH, Hung SH, Chang SP, Lu LC, Lai CC, Lin WT. Pro-, pre- and synbiotics for the prevention of incidental ventilator-associated pneumonia among critically ill patients: a systematic review and meta-analysis of randomized controlled trials. Expert Rev Anti Infect Ther. 2022;16:1\u201311.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"4259_CR159","doi-asserted-by":"publisher","DOI":"10.1093\/nutrit\/nuac059","author":"AS Alsuwaylihi","year":"2022","unstructured":"Alsuwaylihi AS, McCullough F. The safety and efficacy of probiotic supplementation for critically ill adult patients: a systematic review and meta-analysis. Nutr Rev. 2022. https:\/\/doi.org\/10.1093\/nutrit\/nuac059.","journal-title":"Nutr Rev"},{"issue":"4","key":"4259_CR160","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/shk.0b013e31805569df","volume":"28","author":"JA Clark","year":"2007","unstructured":"Clark JA, Coopersmith CM. Intestinal crosstalk\u2014a new paradigm for understanding the gut as the \u201cmotor\u201d of critical illness. Shock Augusta Ga. 2007;28(4):384\u201393.","journal-title":"Shock Augusta Ga"},{"issue":"8","key":"4259_CR161","doi-asserted-by":"publisher","first-page":"3614","DOI":"10.1007\/s12035-021-02357-2","volume":"58","author":"AK George","year":"2021","unstructured":"George AK, Behera J, Homme RP, Tyagi N, Tyagi SC, Singh M. Rebuilding microbiome for mitigating traumatic brain injury: importance of restructuring the gut-microbiome-brain axis. Mol Neurobiol. 2021;58(8):3614\u201327.","journal-title":"Mol Neurobiol"},{"issue":"3","key":"4259_CR162","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3390\/idr14030052","volume":"14","author":"A Corriero","year":"2022","unstructured":"Corriero A, Ribezzi M, Mele F, Angrisani C, Romaniello F, Daleno A, et al. COVID-19 variants in critically Ill patients: a comparison of the delta and omicron variant profiles. Infect Dis Rep. 2022;14(3):492\u2013500.","journal-title":"Infect Dis Rep"},{"key":"4259_CR163","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0954422421000317","volume":"20","author":"KS Batista","year":"2021","unstructured":"Batista KS, de Albuquerque JG, de Vasconcelos MHA, Bezerra MLR, da Silva Barbalho MB, Pinheiro RO, et al. Probiotics and prebiotics: potential prevention and therapeutic target for nutritional management of COVID-19? Nutr Res Rev. 2021;20:1\u201318.","journal-title":"Nutr Res Rev"},{"issue":"2","key":"4259_CR164","doi-asserted-by":"publisher","first-page":"274","DOI":"10.3390\/nu14020274","volume":"14","author":"QV Nguyen","year":"2022","unstructured":"Nguyen QV, Chong LC, Hor YY, Lew LC, Rather IA, Choi SB. Role of probiotics in the management of COVID-19: a computational perspective. Nutrients. 2022;14(2):274.","journal-title":"Nutrients"},{"issue":"4","key":"4259_CR165","doi-asserted-by":"publisher","first-page":"A1148","DOI":"10.1016\/j.chest.2022.08.912","volume":"162","author":"S Mayer","year":"2022","unstructured":"Mayer S, Bonhag CM, Jenkins P, Cornett BT, Scherbak D. Probiotic administration is associated with increased mortality in ICU patients with central venous catheters. Chest. 2022;162(4):A1148.","journal-title":"Chest"},{"issue":"5","key":"4259_CR166","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1186\/s13054-014-0480-6","volume":"18","author":"CE Luyt","year":"2014","unstructured":"Luyt CE, Br\u00e9chot N, Trouillet JL, Chastre J. Antibiotic stewardship in the intensive care unit. Crit Care. 2014;18(5):480.","journal-title":"Crit Care"},{"issue":"2","key":"4259_CR167","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1093\/jac\/dkg095","volume":"51","author":"J Harmoinen","year":"2003","unstructured":"Harmoinen J, Vaali K, Koski P, Syrj\u00e4nen K, Laitinen O, Lindevall K, et al. Enzymic degradation of a beta-lactam antibiotic, ampicillin, in the gut: a novel treatment modality. J Antimicrob Chemother. 2003;51(2):361\u20135.","journal-title":"J Antimicrob Chemother"},{"key":"4259_CR168","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.anaerobe.2016.05.015","volume":"41","author":"M Kaleko","year":"2016","unstructured":"Kaleko M, Bristol JA, Hubert S, Parsley T, Widmer G, Tzipori S, et al. Development of SYN-004, an oral beta-lactamase treatment to protect the gut microbiome from antibiotic-mediated damage and prevent Clostridium difficile infection. Anaerobe. 2016;41:58\u201367.","journal-title":"Anaerobe"},{"key":"4259_CR169","unstructured":"DAV132 Digestive Cancers [Internet]. Da Volterra. [cited 2022 Aug 30]. Available from: https:\/\/davolterra.com\/dav132-digestive-cancers\/"},{"key":"4259_CR170","unstructured":"Blunting the Effects of Antibiotics on the Intestinal Microbiome [Internet]. [cited 2022 Aug 30]. Available from: https:\/\/www.jwatch.org\/na46230\/2018\/03\/06\/blunting-effects-antibiotics-intestinal-microbiome"},{"issue":"70","key":"4259_CR171","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1146\/annurev-med-111717-122956","volume":"27","author":"RE Ooijevaar","year":"2019","unstructured":"Ooijevaar RE, Terveer EM, Verspaget HW, Kuijper EJ, Keller JJ. Clinical application and potential of fecal microbiota transplantation. Annu Rev Med. 2019;27(70):335\u201351.","journal-title":"Annu Rev Med"},{"issue":"1","key":"4259_CR172","first-page":"73","volume":"34","author":"BN Limketkai","year":"2019","unstructured":"Limketkai BN, Hendler S, Ting PS, Parian AM. fecal microbiota transplantation for the critically Ill patient. Nutr Clin Pract Off Publ Am Soc Parenter Enter Nutr. 2019;34(1):73\u20139.","journal-title":"Nutr Clin Pract Off Publ Am Soc Parenter Enter Nutr"},{"issue":"21","key":"4259_CR173","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1056\/NEJMoa1910437","volume":"381","author":"Z DeFilipp","year":"2019","unstructured":"DeFilipp Z, Bloom PP, Torres Soto M, Mansour MK, Sater MRA, Huntley MH, et al. Drug-resistant E. coli bacteremia transmitted by fecal microbiota transplant. N Engl J Med. 2019;381(21):2043\u201350.","journal-title":"N Engl J Med"},{"key":"4259_CR174","unstructured":"Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile | NEJM [Internet]. [cited 2022 Jul 2]. Available from: https:\/\/www.nejm.org\/doi\/full\/10.1056\/nejmoa1205037"},{"key":"4259_CR175","first-page":"12","volume":"226","author":"R Keskey","year":"2020","unstructured":"Keskey R, Cone JT, DeFazio JR, Alverdy JC. The use of fecal microbiota transplant in sepsis. Transl Res J Lab Clin Med. 2020;226:12\u201325.","journal-title":"Transl Res J Lab Clin Med"},{"issue":"12","key":"4259_CR176","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1093\/cid\/ciw185","volume":"62","author":"B Millan","year":"2016","unstructured":"Millan B, Park H, Hotte N, Mathieu O, Burguiere P, Tompkins TA, et al. Fecal microbial transplants reduce antibiotic-resistant genes in patients with recurrent clostridium difficile infection. Clin Infect Dis Off Publ Infect Dis Soc Am. 2016;62(12):1479\u201386.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"1","key":"4259_CR177","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1038\/s41467-020-15545-w","volume":"11","author":"SM Kim","year":"2020","unstructured":"Kim SM, DeFazio JR, Hyoju SK, Sangani K, Keskey R, Krezalek MA, et al. Fecal microbiota transplant rescues mice from human pathogen mediated sepsis by restoring systemic immunity. Nat Commun. 2020;11(1):2354.","journal-title":"Nat Commun"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-022-04259-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-022-04259-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-022-04259-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T10:58:31Z","timestamp":1678964311000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-022-04259-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,7]]},"references-count":177,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["4259"],"URL":"https:\/\/doi.org\/10.1186\/s13054-022-04259-8","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,7]]},"assertion":[{"value":"26 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"379"}}